Your browser doesn't support javascript.
loading
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study.
Di Fusco, Manuela; Mendes, Diana; Steuten, Lotte; Bloom, David E; Drummond, Michael; Hauck, Katharina; Pearson-Stuttard, Jonathan; Power, Rachel; Salisbury, David; Towse, Adrian; Roiz, Julie; Szabo, Gabor; Yang, Jingyan; Marczell, Kinga.
Afiliação
  • Di Fusco M; Health Economics and Outcomes Research, Pfizer Inc., New York, NY 10017, USA.
  • Mendes D; Health & Value, Pfizer Co., Ltd., Tadworth KT20 7NS, UK.
  • Steuten L; Office of Health Economics, London SW1E 6QT, UK.
  • Bloom DE; Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.
  • Drummond M; Centre for Health Economics, Alcuin A Block, University of York, Heslington, York YO10 5DD, UK.
  • Hauck K; Department of Infectious Disease Epidemiology, Faculty of Medicine, School of Public Health, Imperial College London, London W2 1PG, UK.
  • Pearson-Stuttard J; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, UK.
  • Power R; Health Analytics, Lane Clark & Peacock, London W1U 1DQ, UK.
  • Salisbury D; The Patients Association, PO Box 935, Harrow HA1 3YJ, UK.
  • Towse A; Programme for Global Health, Royal Institute of International Affairs, Chatham House, London SW1Y 4LE, UK.
  • Roiz J; Office of Health Economics, London SW1E 6QT, UK.
  • Szabo G; Evidence, Value and Access by PPD, Evidera, London W6 8BJ, UK.
  • Yang J; Evidence, Value and Access by PPD, Evidera, H-1113 Budapest, Hungary.
  • Marczell K; Health Economics and Outcomes Research, Pfizer Inc., New York, NY 10017, USA.
Vaccines (Basel) ; 11(2)2023 Jan 20.
Article em En | MEDLINE | ID: mdl-36851112
ABSTRACT
Health technology assessments (HTAs) of vaccines typically focus on the direct health benefits to individuals and healthcare systems. COVID-19 highlighted the widespread societal impact of infectious diseases and the value of vaccines in averting adverse clinical consequences and in maintaining or resuming social and economic activities. Using COVID-19 as a case study, this research work aimed to set forth a conceptual framework capturing the broader value elements of vaccines and to identify appropriate methods to quantify value elements not routinely considered in HTAs. A two-step approach was adopted, combining a targeted literature review and three rounds of expert elicitation based on a modified Delphi method, leading to a conceptual framework of 30 value elements related to broader health effects, societal and economic impact, public finances, and uncertainty value. When applying the framework to COVID-19 vaccines in post-pandemic settings, 13 value elements were consensually rated highly important by the experts for consideration in HTAs. The experts reviewed over 10 methods that could be leveraged to quantify broader value elements and provided technical forward-looking recommendations. Limitations of the framework and the identified methods were discussed. This study supplements ongoing efforts aimed towards a broader recognition of the full societal value of vaccines.
Palavras-chave

Texto completo: 1 Temas: ECOS / Avaliacao_tecnologia Bases de dados: MEDLINE Tipo de estudo: Guideline / Health_technology_assessment Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Temas: ECOS / Avaliacao_tecnologia Bases de dados: MEDLINE Tipo de estudo: Guideline / Health_technology_assessment Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos